Latrax
neuro wide solutions
Client
Latrax
Category
Healthcare
Year
2018
About Latrax

Epilepsy is a chronic disorder of the brain that affects people of all ages. Approximately 50 million people currently live with epilepsy worldwide, making it one of the most common neurological diseases globally. 3/4 of people with epilepsy living in low- and middle- income countries do not get the treatment they need. WHY? The lack or severe shortage of appropriately trained staff, the low availability of anti-epileptic medicines, the lack of public awareness and cultural beliefs, the cost of medication. The solution is LATRAX - VNS Therapy ‘vagus nerve stimulation’- an adjunctive therapy in reducing seizure frequency in adults and adolescents over age of 12 with partial-onset seizure that are refractory to anti epileptic drugs.

  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
  • portfolio
The Challenge

TASK: to build a brand for Ukrainian medical start up LATRAX - vagus nerve stimulator, to gain investments and expand globally.

BRAND POSITIONING: NEURO WIDE SOLUTIONS.

After being greatly presented at the first Ukrainian biomedical contest startups MBioS Challenge 2018, LATRAX won the contest being awarded and supported for the final rounds in Vilnius and London. We are proud to take a part in this great solution that the whole world needs. Congrats!


 
We'd love to hear about your name
Start now